United States · FDA National Drug Code directory
Alogliptin and Pioglitazone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-402_11c471e0-6c64-4f13-b6ed-d2c80bc89f20
- Product NDC
- 45802-402
- Form
- TABLET, FILM COATED
- Composition / generic term
- Alogliptin Benzoate and Pioglitazone hydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20160408
- Source listing expiry
- 20261231
Source-listed ingredients
- ALOGLIPTIN BENZOATE — 25 mg/1
- PIOGLITAZONE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (45802-402-65) · 45802-402-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →